Aspire Biopharma Holdings, Inc.
ASBP
$8.87
-$0.38-4.11%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.17M | 5.86M | 1.00M | 1.95M | 206.20K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | 288.50K | 370.00K | 253.20K | 35.40K | -- |
| Prepaid Expenses | 1.01M | 890.10K | 55.10K | 419.40K | 783.20K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 13.47M | 7.12M | 1.31M | 2.40M | 989.40K |
|
|
|||||
| Total Current Assets | 13.47M | 7.12M | 1.31M | 2.40M | 989.40K |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 75.00K | -- | -- | -- | -- |
| Total Assets | 13.54M | 7.12M | 1.31M | 2.40M | 989.40K |
|
|
|||||
| Total Accounts Payable | 972.10K | 857.90K | 1.01M | 1.06M | 1.35M |
| Total Accrued Expenses | 714.10K | 795.30K | 1.36M | 620.60K | 731.90K |
| Short-term Debt | -- | 1.50M | 5.18M | 8.62M | 8.47M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 41.00K | 3.55M | -- |
| Total Other Current Liabilities | -- | -- | 41.00K | 3.55M | -- |
| Total Current Liabilities | 1.69M | 3.15M | 7.59M | 13.86M | 10.56M |
|
|
|||||
| Total Current Liabilities | 1.69M | 3.15M | 7.59M | 13.86M | 10.56M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 1.50M | 5.18M | 8.62M | 8.47M |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 96.50K | 96.30K | 95.70K | 9.90K | 49.30K |
| Total Liabilities | 1.78M | 3.25M | 7.69M | 13.87M | 10.61M |
|
|
|||||
| Common Stock & APIC | 43.51M | 34.35M | 20.88M | 11.08M | 11.08M |
| Retained Earnings | -31.75M | -30.48M | -27.26M | -22.55M | -20.70M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 11.76M | 3.87M | -6.38M | -11.47M | -9.62M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | -- | -- | -- |
|
|
|||||
| Total Common Equity | 11.76M | 3.87M | -6.38M | -11.47M | -9.62M |
| Total Preferred Equity | 0.00 | 0.00 | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 11.76M | 3.87M | -6.38M | -11.47M | -9.62M |
|
|
|||||